Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?

The preclinical diagnosis and clinical practice for Alzheimer’s disease (AD) based on liquid biopsy have made great progress in recent years. As liquid biopsy is a fast, low-cost, and easy way to get the phase of AD, continual efforts from intense multidisciplinary studies have been made to move the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Xun, Zhang, Hantao, Liu, Xiaoyan, Liu, Yi, Liu, Junlin, Fapohunda, Funmilayo O., Lü, Peng, Wang, Kun, Tang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389010/
https://www.ncbi.nlm.nih.gov/pubmed/35992602
http://dx.doi.org/10.3389/fnagi.2022.977999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389010/
https://www.ncbi.nlm.nih.gov/pubmed/35992602
http://dx.doi.org/10.3389/fnagi.2022.977999

Ejemplares similares